Long-term Epidemiological Follow-up of Non-small Cell Lung Cancer in Scandinavia (SCAN-LEAF)

Bristol-Myers Squibb (BMS)

Status: Completed

Conditions: Non-Small Cell Lung Cancer

Study type: Observational

Funder types: Industry

Identifiers

NCT02839629

CA209-319

Details and patient eligibility

About

A study to describe and evaluate patient characteristics and clinical outcomes in Subjects with diagnosed Non Small Lung Cell Cancer in Sweden, Norway and Denmark.

Enrollment: 5,657 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Patients with a histologically confirmed diagnosis of NSCLC (squamous, adenocarcinoma, not otherwise specified NSCLC [NSCLC NOS]) identified in the Cancer registers

Exclusion criteria

• Age under 18 years at time of diagnosis

Trial design

5,657 participants in 2 patient groups

Cohort 1: National patient cohorts in Scandinavia

Description:

Scandinavian countries: Denmark, Norway and Sweden Cohort 1 will include all patients with a diagnosis of NSCLC between 2005 and 2013

Cohort 2: Electronic Medical Records based cohort (Sweden)

Description:

Patient as data is available (\~2010) to 2013